In-Utero Treatment of Fetal SVT: A Case Report
Vineeta Gupta1, Shweta Nimonkar1, Swati Kohli1
1Department of Obstetrics and Gynacology, SGRRIHM&S & Shri Mahant Indiresh Hospital, Patel Nagar, Dehra Dun, Uttarakhand 248001 India.
Fetal supraventricular tachycardia may lead to low cardiac output, nonimmune hydrops and fetal demise. We are presenting an antenatal case in whom fetal SVT was picked up during examination and was confirmed by ultrasound and fetal echocardiography. Following administration of flecainide to mother, fetal SVT improved, baby did not develop hydrops, pregnancy continued till term and patient delivered vaginally. Awareness regarding existence of fetal arrhythmias is important for obstetricians as early diagnosis and treatment before development of fetal hydrops will not only help in improving fetal outcome but also in reducing cesarean section rates in these cases.
Fetal supraventricular tachycardia may lead to low cardiac output, nonimmune hydrops and fetal demise. We are presenting an antenatal case in whom fetal SVT was picked up during examination and was confirmed by ultrasound and fetal echocardiography. Following administration of flecainide to mother, fetal SVT improved, baby did not develop hydrops, pregnancy continued till term and patient delivered vaginally. Awareness regarding existence of fetal arrhythmias is important for obstetricians as early diagnosis and treatment before development of fetal hydrops will not only help in improving fetal outcome but also in reducing cesarean section rates in these cases.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
19:04In Utero Intraventricular Injection and Electroporation of E16 Rat Embryos
Published on: July 19, 2007
